Cipla acquisition: Report warns of EPS dilution despite funding as Torrent Pharma and Dr Reddy's eye pharma major
Kotak Institutional Equities found minimal portfolio overlap between Torrent Pharma and Cipla, thus limiting synergies
Source: businesstoday.in